“…Although a global understanding of the molecular background of FTD is far from being achieved, one can schematically consider that this group includes a large but poorly defined subgroup of typical FTD cases characterized by nonspecific histopathological changes (such as neuronal loss, spongiosis and gliosis), two tauopathies [Pick's disease and FTD and parkinsonism linked to chromosome 17 (FTDP-17)], and one ubiquitinrelated disorder, FTD with motor neuron disease (MND) [8,30,41]. This latter form is characterized clinically by the presence of MND with dementia and neuropathologically by the formation of ubiquitin-positive and tau-negative intraneuronal inclusions in hippocampus and subcortical structures [3,7,9,11,27,31,42,46]. However, ubiquitin-positive intraneuronal inclusions and dendrites have also been reported in familial [6,20,24,35] and in a few sporadic FTD cases in the absence of MND [2,15,18,21,22,36,40,47,48] as well as in FTDP-17 cases [17,28,35].…”